SEUD Congress

Attendees, exhibitors & solutions

Who this event is for

Industry trends

Key trends shaping this market and its wider industry.

Arrival airports

Choose from the following airports, with convenient access to the event and venue.

Hotel tiers

A range of accommodation options near the venue and across key areas.

Local transport

Get around the city with these convenient transport options.

Frequently asked

Glossary

1

Endometriosis

A chronic inflammatory condition in which tissue resembling the uterine lining grows outside the uterus, commonly on the pelvic peritoneum, ovaries and bowel, causing pain and subfertility. It is the central clinical focus of the SEUD congress programme.

2

Adenomyosis

Presence of endometrial glands and stroma within the myometrium, associated with heavy menstrual bleeding, dysmenorrhoea and uterine enlargement; imaging phenotyping and medical versus surgical management are recurring congress topics.

3

Deep infiltrating endometriosis (DIE)

Endometriotic lesions penetrating more than about 5 mm into tissue, frequently involving the rectovaginal septum, bowel, bladder or ureters, and requiring specialised surgical planning.

4

Dysmenorrhoea

Painful menstruation, either primary (no identifiable pelvic pathology) or secondary (for example to endometriosis or adenomyosis); a core symptom endpoint in the trials and care-pathway sessions presented at the meeting.

5

GnRH antagonist

A class of drug that blocks gonadotropin-releasing hormone receptors to suppress ovarian oestrogen production, used as oral therapy for endometriosis-associated pain and as a central topic in industry symposia.

6

Progestin

Synthetic progestogen used first-line to suppress endometriotic tissue; dosing routes, tolerability and long-term bone effects are typically debated in the congress medical-management tracks.

7

Fertility preservation

Strategies such as oocyte or embryo cryopreservation offered before endometriosis surgery or gonadotoxic treatment; relevant to the reproductive-medicine audience attending SEUD.

8

Transvaginal ultrasound (TVUS) mapping

Structured sonographic assessment of pelvic compartments used to predict deep endometriosis involvement and plan surgery; a recurring hands-on and imaging-session theme.

9

Chronic pelvic pain (CPP)

Pain in the pelvic region lasting six months or more, often requiring combined gynaecological, pain-medicine and physiotherapy input rather than surgery alone.

10

Multidisciplinary team (MDT) care

Coordinated management of complex endometriosis by gynaecologists, colorectal and urological surgeons, radiologists, pain specialists, nurses and physiotherapists, a model promoted across the congress programme.

11

ESHRE guideline

European Society of Human Reproduction and Embryology guidance on endometriosis diagnosis and management, widely used as the reference framework for European care pathways discussed at the congress.

12

Patient-reported outcome measure (PROM)

Validated questionnaire capturing pain, dyschezia, dyspareunia or quality of life, used in endometriosis trials and in routine follow-up of surgical and medical treatment.